News

May 16, 2016May 16, 2016

AstraZeneca to Spotlight Respiratory Medicine ATS 2016

Asthma, COPD, News

The biopharmaceutical AstraZeneca recently announced key presentations set to spotlight its large respiratory disease medicines repertoire, during the American Thoracic Society (ATS) International Conference in San Francisco through May 18. The data ... Read more

May 16, 2016May 16, 2016

ATS 2016: Bayer Presents Data on Adempas for Pulmonary Hypertension

News, Pulmonary Hypertension

Bayer is presenting six abstracts at the American Thoracic Society (ATS) 2016 International Conference through May 18 in San Francisco, Calif. The presentations highlight the use of Adempas (riociguat) for pulmonary ... Read more

May 16, 2016May 16, 2016

Aradigm’s Candidates for NCFBE Featured at ATS 2016

Bronchiectasis, Cystic Fibrosis, News

The American Thoracic Society (ATS) is hosting the ATS 2016 International Conference through May 18 in San Francisco, Calif. Aradigm, an emerging pharmaceutical focused on drugs for the prevention and ... Read more

May 13, 2016May 13, 2016

Theravance Poster to Show Phase 3 ATTAIN Trial Results on Pneumonia at ATS 2016

News, Pneumonia

Theravance Biopharma, Inc. recently announced in a press release the presentation of new data on VIBATIV® (telavancin), the company’s FDA-approved antibiotic, at the American Thoracic Society (ATS) 2016 International Conference, May 13-18 in San Francisco. The ... Read more

May 13, 2016May 13, 2016

GlaxoSmithKline (GSK) to Present Studies on Respiratory Diseases Therapies at ATS 2016

Asthma, COPD, News

GlaxoSmithKline (GSK) recently announced that the company will present the most recent results obtained in a wide range of GSK studies, focused on their respiratory portfolio of approved medicines, at ... Read more

May 13, 2016May 13, 2016

ATS 2016 International Conference Features Keynote Series

COPD, Idiopathic Pulmonary Fibrosis, News, Pulmonary Hypertension

The American Thoracic Society (ATS) is hosting the ATS 2016 International Conference through May 18 in San Franscico, Calif. This year’s conference will feature the ATS Keynote Series with eight ... Read more

May 12, 2016May 12, 2016

Hospital Stays for Children with Aspiration Pneumonia Longer, Pricier than Community-Acquired

News, Pneumonia

A recent study presented at the Pediatric Academic Societies Meeting, April 30-May 3 in Baltimore, Md., suggests that hospitalizations of children with aspiration pneumonia (AP) last longer and cost more ... Read more

May 12, 2016May 13, 2016

Veracyte to Show Data on Lung Disease Genomic Classifiers at ATS 2016

Idiopathic Pulmonary Fibrosis, Lung Cancer, News

Veracyte, Inc. will present results at the American Thoracic Society (ATS) 2016 International Conference from multiple trials supporting the company’s genomic tests that may resolve uncertainty in lung disease diagnosis. The company ... Read more

May 12, 2016May 12, 2016

CF Foundation Exhibit at Rockerfeller Center shows Challenges, Progress in CF Fight

Cystic Fibrosis, News

The Cystic Fibrosis Foundation is featuring through May, at Rockefeller Center in New York, an impressive window display to raise awareness about cystic fibrosis (CF) – thanks to the space ... Read more

May 11, 2016May 11, 2016

Study Bolsters Support for Newborn Cystic Fibrosis Screenings in Quebec

Cystic Fibrosis, News

A new study led by a team from the Research Institute of the McGill University Health Centre (RI-MUHC) and Cystic Fibrosis Canada strongly supports the benefits of newborn screening programs ... Read more